Neo Ivy Capital Management - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of INSMED INC
ValueSharesWeighting
Q4 2022$116
-99.9%
5,790
-32.9%
0.08%
-84.0%
Q3 2022$186,000
+431.4%
8,631
+374.0%
0.49%
+420.2%
Q2 2022$35,000
-62.8%
1,821
-54.8%
0.09%
+10.6%
Q1 2022$94,000
+422.2%
4,026
+494.7%
0.08%
+226.9%
Q4 2021$18,000
+38.5%
677
+48.5%
0.03%
+73.3%
Q3 2021$13,000
-72.3%
456
-72.6%
0.02%
-68.1%
Q2 2021$47,000
+261.5%
1,667
+265.6%
0.05%
+840.0%
Q2 2020$13,0004560.01%
Other shareholders
INSMED INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$148,709,64814.07%
Deep Track Capital, LP 6,000,000$151,500,0005.85%
Octagon Capital Advisors LP 1,284,000$32,421,0004.98%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,446,334$87,019,9344.70%
MPM BioImpact LLC 527,458$13,318,3153.56%
Novo Holdings A/S 1,339,304$33,817,4262.50%
Bleichroeder LP 325,000$8,206,2502.02%
GREAT POINT PARTNERS LLC 394,872$9,970,5181.82%
Endurant Capital Management LP 79,471$2,006,6431.80%
SECTORAL ASSET MANAGEMENT INC 347,392$8,771,6481.71%
View complete list of INSMED INC shareholders